gliclazide and ER-Negative PR-Negative HER2-Negative Breast Cancer

gliclazide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Datta, D; Khan, F; Meena, S; Shukla, A; Srivastava, SK; Tyagi, R	1

Other Studies

1 other study(ies) available for gliclazide and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
2D- and 3D-QSAR modelling, molecular docking and Journal of biomolecular structure & dynamics, 2020, Volume: 38, Issue:1 Topics: Algorithms; Antineoplastic Agents; Cell Line, Tumor; Glycyrrhetinic Acid; Humans; Hydrolysis; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Quantitative Structure-Activity Relationship; Triple Negative Breast Neoplasms	2020

Article

Year

2D- and 3D-QSAR modelling, molecular docking and

Journal of biomolecular structure & dynamics, 2020, Volume: 38, Issue:1

Topics: Algorithms; Antineoplastic Agents; Cell Line, Tumor; Glycyrrhetinic Acid; Humans; Hydrolysis; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Quantitative Structure-Activity Relationship; Triple Negative Breast Neoplasms

2020